04 December 2018

Australia’s first long-acting treatment for opioid dependence now TGA approved

6 minute read

The approval of Buvidal Weekly and Buvidal Monthly will, for the first time, give Australian patients access to a long-acting buprenorphine treatment for opioid dependence [SPONSORED]

This content is for members only.
Login Join Now

End of content

No more pages to load

Register for a new account

Username

Password

Confirm Password

First Name

Last Name

Email Address

Full Name LEAVE THIS BLANK

What field do you work in?

Specialty:

Type of University work:

Industry Specialty:

Other:

Billing Address

First Name

Last Name

Address 1

Address 2

City

State

Postal Code

Country

Phone

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Card Number

Expiration Date /

Security Code (CVC) (what's this?)

Processing...

Australia’s first long-acting treatment for opioid dependence now TGA approved

Coming up: Ophthalmology update: New treatments for old conditions

No Phenergan for under-6s: TGA

T2D remission the ‘best-case scenario’

Register for a new account

Billing Address

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Log in

Register for a new account

Billing Address

Payment Information We Accept Visa, Mastercard, American Express, and Discover